Zie ook deze search met het woord diabetes in de titels van artikelen op onze website.

Overigens is diabetes-2 meestal te genezen via een gezonde leefstijl met veel bewegen en sporten plus aangepast voedingspatroon met veel groenten en fruit en soms vette vis. Mensen met diabetes-2 krijgen dit ook vergoed en kunnen een gezondheidsprogramma volgen onder begeleiding. Zie ook dit artikel op onze website.

14 december 2024: Bron: GUT

Uit studiegegevens gepubliceerd in GUT stellen de onderzoekers dat het natuurlijke alkaloid Harmine (Harmijn) via de betacellen de insulineproductie herstelt. Wat zou betekenen dat diabetes, zowel diabetes 1 als 2 te genezen zou zijn met dit medicijn. Harmine (Harmijn) maakt deel uit van een groep medicijnen die DYRK1A-remmers worden genoemd en al eerder werden deze medicijnen gelinkt aan herstel van de insulineproductie. In een nieuwe studie herstelde Harmine (Harmijn) samen met GLP-1-receptoragonisten zoals semaglutide en exenatide de productie van insuline via de bèta-cellen. 

De onderzoekers onder leiding van prof. dr. Esra Karakose voerden in het verleden verschillende laboratoriumstudies uit en hebben nu een dierstudie met muizen zonder immuunsysteem opgezet die opmerkelijke resultaten laat zien.  De onderzoekers transplanteerden een klein aantal menselijke bètacellen in muizen zonder immuunsysteem, een situatie dat in principe model staat voor diabetes type 1 en type 2. De muizen werden behandeld met de combinatietherapie van Harmine (Harmijn) samen met GLP-1-receptoragonisten. Wat de onderzoekers zagen was heel opmerkelijk want binnen drie maanden na de start van de behandeling kwam de insulineproductie weer op gang en verdween de diabetes. Wat nog belangrijker lijkt is dat het aantal menselijke bètacellen met 700 procent toe nam mede onder invloed van alfacellen die veelvuldig voorkomen in de alvleesklier. Blijkbaar spelen deze alfacellen een grote rol in het nieuw  produceren van menselijke bètacellen. Aldus schrijven de onderzoekers in hun studieverslag. 

De ontdekking dat alfacellen in de alvleesklier kunnen worden omgezet in bèta-cellen biedt nieuwe hoop voor zowel type 1 als type 2 diabetespatiënten. “Dit is een heel belangrijke ontdekking die laat zien dat medicijnen uit de harmine-familie mogelijk de omzetting van cellen in de menselijke eilandjes van Langerhans kunnen stimuler
en”, aldus onderzoeker Esra Karakose in een toelichting op hun studiepresentatie. “Dit zou betekenen dat mensen met alle vormen van diabetes veel potentiële  bèta-cellen hebben, die zouden geactiveerd kunnen worden door medicijnen zoals Harmine (Harmijn) al of niet in combinatie met andere medicijnen.”

Het volledige studieverslag is gratis in te zien of te downloaden. Klik daarvoor op de titel van het abstract:

Cover Image - Cell Reports Medicine, Volume 0, Issue 0

Highlights

All previously annotated cell types are present in regenerative drug-treated human islets
Cycling alpha cells uniquely fulfill characteristics for regenerative drug-responsive cells
Regenerative drugs increase beta cell phenotypic markers in cycling alpha cells
Conversion of cycling alpha cells to beta cells contributes to beta cell mass expansion

Summary

Diabetes results from an inadequate number of insulin-producing human beta cells. There is currently no clinically available effective means to restore beta cell mass in millions of people with diabetes. Although the DYRK1A inhibitors, either alone or in combination with GLP-1 receptor agonists (GLP-1) or transforming growth factor β (TGF-β) superfamily inhibitors (LY), induce beta cell replication and increase beta cell mass, the precise mechanisms of action remain elusive. Here we perform single-cell RNA sequencing on human pancreatic islets treated with a DYRK1A inhibitor, either alone or with GLP-1 or LY. We identify cycling alpha cells as the most responsive cells to DYRK1A inhibition. Lineage trajectory analyses suggest that cycling alpha cells may serve as precursor cells that transdifferentiate into beta cells. Collectively, in addition to enhancing expression of beta cell phenotypic genes in beta cells, our findings suggest that regenerative drugs may be targeting cycling alpha cells in human islets.

Supplemental information (4)

Document S1. Figures S1–S8 and Tables S3 and S4
Table S1. Excel file containing the list of upregulated genes in the Cycling Alpha cluster vs. all other clusters, related to Figure 4
Table S2. Excel file containing the list of upregulated genes in clusters 0-1-2 of the Cycling Alpha cluster, related to Figure 5
Document S2. Article plus supplemental information

References

1.
IDF Diabetes Atlas
Brussels, Belgium, 2021
2.
Karakose, E. ∙ Ackeifi, C. ∙ Wang, P. ...
Advances in drug discovery for human beta cell regeneration
Diabetologia. 2018; 61:1693-1699
3.
Dirice, E. ∙ Walpita, D. ∙ Vetere, A. ...
Inhibition of DYRK1A Stimulates Human beta-Cell Proliferation
Diabetes. 2016; 65:1660-1671
4.
Abdolazimi, Y. ∙ Zhao, Z. ∙ Lee, S. ...
CC-401 Promotes beta-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition
Endocrinology. 2018; 159:3143-3157
5.
Shen, W. ∙ Taylor, B. ∙ Jin, Q. ...
Inhibition of DYRK1A and GSK3B induces human beta-cell proliferation
Nat. Commun. 2015; 6:8372
6.
Aamodt, K.I. ∙ Aramandla, R. ∙ Brown, J.J. ...
Development of a reliable automated screening system to identify small molecules and biologics that promote human beta-cell regeneration
Am. J. Physiol. Endocrinol. Metab. 2016; 311:E859-E868
7.
Wang, P. ∙ Alvarez-Perez, J.C. ∙ Felsenfeld, D.P. ...
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Nat. Med. 2015; 21:383-388
8.
Ackeifi, C. ∙ Wang, P. ∙ Karakose, E. ...
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration
Sci. Transl. Med. 2020; 12, eaaw9996
9.
Ackeifi, C. ∙ Swartz, E. ∙ Kumar, K. ...
Pharmacologic and genetic approaches define human pancreatic beta cell mitogenic targets of DYRK1A inhibitors
JCI Insight. 2020; 5, e132594
10.
Wang, P. ∙ Karakose, E. ∙ Liu, H. ...
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Cell Metabol. 2019; 29:638-652.e5
11.
Kumar, K. ∙ Wang, P. ∙ Wilson, J. ...
Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human beta-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor
J. Med. Chem. 2020; 63:2986-3003
12.
Dhawan, S. ∙ Dirice, E. ∙ Kulkarni, R.N. ...
Inhibition of TGF-beta Signaling Promotes Human Pancreatic beta-Cell Replication
Diabetes. 2016; 65:1208-1218
13.
Liu, Y.A. ∙ Jin, Q. ∙ Zou, Y. ...
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
J. Med. Chem. 2020; 63:2958-2973
14.
Wang, Y.J. ∙ Golson, M.L. ∙ Schug, J. ...
Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
Cell Metabol. 2016; 24:616-626
15.
Rosselot, C. ∙ Li, Y. ∙ Wang, P. ...
Harmine and exendin-4 combination therapy safely expands human beta cell mass in vivo in a mouse xenograft system
Sci. Transl. Med. 2024; 16, eadg3456
16.
Thorel, F. ∙ Népote, V. ∙ Avril, I. ...
Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss
Nature. 2010; 464:1149-1154
17.
Chera, S. ∙ Baronnier, D. ∙ Ghila, L. ...
Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers
Nature. 2014; 514:503-507
18.
Nir, T. ∙ Melton, D.A. ∙ Dor, Y.
Recovery from diabetes in mice by beta cell regeneration
J. Clin. Invest. 2007; 117:2553-2561
19.
Furuyama, K. ∙ Chera, S. ∙ van Gurp, L. ...
Diabetes relief in mice by glucose-sensing insulin-secreting human alpha-cells
Nature. 2019; 567:43-48
20.
Lee, S. ∙ Zhang, J. ∙ Saravanakumar, S. ...
Virgin beta-Cells at the Neogenic Niche Proliferate Normally and Mature Slowly
Diabetes. 2021; 70:1070-1083
21.
van der Meulen, T. ∙ Mawla, A.M. ∙ DiGruccio, M.R. ...
Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets
Cell Metabol. 2017; 25:911-926.e6
22.
Lam, C.J. ∙ Cox, A.R. ∙ Jacobson, D.R. ...
Highly Proliferative alpha-Cell-Related Islet Endocrine Cells in Human Pancreata
Diabetes. 2018; 67:674-686
23.
Minami, K. ∙ Okuno, M. ∙ Miyawaki, K. ...
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells
Proc. Natl. Acad. Sci. USA. 2005; 102:15116-15121
24.
Dirice, E. ∙ Basile, G. ∙ Kahraman, S. ...
Single-nucleus RNA-Seq reveals singular gene signatures of human ductal cells during adaptation to insulin resistance
JCI Insight. 2022; 7, e153877
25.
Magenheim, J. ∙ Maestro, M.A. ∙ Sharon, N. ...
Matters arising: Insufficient evidence that pancreatic beta cells are derived from adult ductal Neurog3-expressing progenitors
Cell Stem Cell. 2023; 30:488-497.e3
26.
Klein, D. ∙ Álvarez-Cubela, S. ∙ Lanzoni, G. ...
BMP-7 Induces Adult Human Pancreatic Exocrine-to-Endocrine Conversion
Diabetes. 2015; 64:4123-4134
27.
Qadir, M.M.F. ∙ Álvarez-Cubela, S. ∙ Klein, D. ...
P2RY1/ALK3-Expressing Cells within the Adult Human Exocrine Pancreas Are BMP-7 Expandable and Exhibit Progenitor-like Characteristics
Cell Rep. 2018; 22:2408-2420
28.
Qadir, M.M.F. ∙ Álvarez-Cubela, S. ∙ Klein, D. ...
Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche
Proc. Natl. Acad. Sci. USA. 2020; 117:10876-10887
29.
Ngara, M. ∙ Wierup, N.
Lessons from single-cell RNA sequencing of human islets
Diabetologia. 2022; 65:1241-1250
30.
Elgamal, R.M. ∙ Kudtarkar, P. ∙ Melton, R.L. ...
An integrated map of cell type-specific gene expression in pancreatic islets
Preprint atbioRxiv. 2023;
31.
Kaestner, K.H. ∙ Powers, A.C. ∙ Naji, A., HPAP Consortium
NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP)
Diabetes. 2019; 68:1394-1402
32.
Xin, Y. ∙ Adler, C. ∙ Kim, J. ...
Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets.
J. Vis. Exp. 2019; PMID: 31380847
33.
Hao, Y. ∙ Hao, S. ∙ Andersen-Nissen, E. ...
Integrated analysis of multimodal single-cell data
Cell. 2021; 184:3573-3587.e29
34.
Charytonowicz, D. ∙ Brody, R. ∙ Sebra, R.
Interpretable and context-free deconvolution of multi-scale whole transcriptomic data with UniCell deconvolve
Nat. Commun. 2023; 14:1350
35.
Elgamal, R.M. ∙ Kudtarkar, P. ∙ Melton, R.L. ...
An integrated map of cell type-specific gene expression in pancreatic islets
Diabetes. 2023; 72:1719-1728
36.
Walker, J.T. ∙ Saunders, D.C. ∙ Rai, V. ...
Genetic risk converges on regulatory networks mediating early type 2 diabetes
Nature. 2023; 624:621-629
37.
Dann, E. ∙ Henderson, N.C. ∙ Teichmann, S.A. ...
Differential abundance testing on single-cell data using k-nearest neighbor graphs
Nat. Biotechnol. 2022; 40:245-253
38.
Gregg, B.E. ∙ Moore, P.C. ∙ Demozay, D. ...
Formation of a human beta-cell population within pancreatic islets is set early in life
J. Clin. Endocrinol. Metab. 2012; 97:3197-3206
39.
Kassem, S.A. ∙ Ariel, I. ∙ Thornton, P.S. ...
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
Diabetes. 2000; 49:1325-1333
40.
Patil, A.R. ∙ Schug, J. ∙ Naji, A. ...
Single-cell expression profiling of islets generated by the Human Pancreas Analysis Program
Nat. Metab. 2023; 5:713-715
41.
Grun, D. ∙ Muraro, M.J. ∙ Boisset, J.C. ...
De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data
Cell Stem Cell. 2016; 19:266-277
42.
Muraro, M.J. ∙ Dharmadhikari, G. ∙ Grun, D. ...
A Single-Cell Transcriptome Atlas of the Human Pancreas
Cell systems. 2016; 3:385-394.e383
43.
Enge, M. ∙ Arda, H.E. ∙ Mignardi, M. ...
Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns
Cell. 2017; 171:321-330.e14
44.
Kang, R.B. ∙ Li, Y. ∙ Rosselot, C. ...
Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes beta-cell subpopulations with dynamic transcriptome profiles
Genome Med. 2023; 15:30
45.
Lawlor, N. ∙ George, J. ∙ Bolisetty, M. ...
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes
Genome Res. 2017; 27:208-222
46.
Shrestha, S. ∙ Erikson, G. ∙ Lyon, J. ...
Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress
Sci. Adv. 2022; 8, eabo3932
47.
Dominguez Gutierrez, G. ∙ Kim, J. ∙ Lee, A.H. ...
Gene Signature of the Human Pancreatic epsilon Cell
Endocrinology. 2018; 159:4023-4032
48.
Augsornworawat, P. ∙ Hogrebe, N.J. ∙ Ishahak, M. ...
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Nat. Cell Biol. 2023; 25:904-916
49.
Chiou, J. ∙ Zeng, C. ∙ Cheng, Z. ...
Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk
Nat. Genet. 2021; 53:455-466
50.
Augsornworawat, P. ∙ Maxwell, K.G. ∙ Velazco-Cruz, L. ...
Single-Cell Transcriptome Profiling Reveals beta Cell Maturation in Stem Cell-Derived Islets after Transplantation
Cell Rep. 2020; 32, 108067
51.
Segerstolpe, Å. ∙ Palasantza, A. ∙ Eliasson, P. ...
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Cell Metabol. 2016; 24:593-607
52.
Wang, Y.J. ∙ Schug, J. ∙ Won, K.J. ...
Single-Cell Transcriptomics of the Human Endocrine Pancreas
Diabetes. 2016; 65:3028-3038
53.
Shrestha, S. ∙ Saunders, D.C. ∙ Walker, J.T. ...
Combinatorial transcription factor profiles predict mature and functional human islet alpha and beta cells
JCI Insight. 2021; 6, e151621
54.
Wang, P. ∙ Karakose, E. ∙ Argmann, C. ...
Disrupting the DREAM complex enables proliferation of adult human pancreatic beta cells
J. Clin. Invest. 2022; 132, e157086
55.
Collombat, P. ∙ Xu, X. ∙ Ravassard, P. ...
The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells
Cell. 2009; 138:449-462
56.
Zhang, Y. ∙ Fava, G.E. ∙ Wang, H. ...
PAX4 Gene Transfer Induces alpha-to-beta Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment
Mol. Ther. 2016; 24:251-260
57.
Chakravarthy, H. ∙ Gu, X. ∙ Enge, M. ...
Converting Adult Pancreatic Islet alpha Cells into beta Cells by Targeting Both Dnmt1 and Arx
Cell Metabol. 2017; 25:622-634
58.
Li, J. ∙ Casteels, T. ∙ Frogne, T. ...
Artemisinins Target GABA(A) Receptor Signaling and Impair alpha Cell Identity
Cell. 2017; 168:86-100.e15
59.
Ben-Othman, N. ∙ Vieira, A. ∙ Courtney, M. ...
Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis
Cell. 2017; 168:73-85.e11
60.
Ackermann, A.M. ∙ Moss, N.G. ∙ Kaestner, K.H.
GABA and Artesunate Do Not Induce Pancreatic alpha-to-beta Cell Transdifferentiation In Vivo
Cell Metabol. 2018; 28:787-792.e3
61.
van der Meulen, T. ∙ Lee, S. ∙ Noordeloos, E. ...
Artemether Does Not Turn alpha Cells into beta Cells
Cell Metabol. 2018; 27:218-225.e4
62.
Xiao, X. ∙ Guo, P. ∙ Shiota, C. ...
Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes
Cell Stem Cell. 2018; 22:78-90.e4
63.
Shapira, S.N. ∙ Naji, A. ∙ Atkinson, M.A. ...
Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program
Cell Metabol. 2022; 34:1906-1913
64.
Hart, N.J. ∙ Powers, A.C.
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Diabetologia. 2019; 62:212-222
65.
Title, A.C. ∙ Karsai, M. ∙ Mir-Coll, J. ...
Evaluation of the Effects of Harmine on beta-cell Function and Proliferation in Standardized Human Islets Using 3D High-Content Confocal Imaging and Automated Analysis
Front. Endocrinol. 2022; 13, 854094
66.
Fleming, S.J. ∙ Chaffin, M.D. ∙ Arduini, A. ...
Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Preprint atbioRxiv. 2022;
67.
Korsunsky, I. ∙ Millard, N. ∙ Fan, J. ...
Fast, sensitive and accurate integration of single-cell data with Harmony
Nat. Methods. 2019; 16:1289-1296
68.
Bergen, V. ∙ Lange, M. ∙ Peidli, S. ...
Generalizing RNA velocity to transient cell states through dynamical modeling
Nat. Biotechnol. 2020; 38:1408-1414
69.
La Manno, G. ∙ Soldatov, R. ∙ Zeisel, A. ...
RNA velocity of single cells
Nature. 2018; 560:494-498
70.
Virshup, I. ∙ Rybakov, S. ∙ Theis, F.J. ...
anndata: Annotated data
Preprint atbioRxiv. 2021;
71.
Wolf, F.A. ∙ Angerer, P. ∙ Theis, F.J.
SCANPY: large-scale single-cell gene expression data analysis
Genome Biol. 2018; 19:15
72.
Wolf, F.A. ∙ Hamey, F.K. ∙ Plass, M. ...
PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells
Genome Biol. 2019; 20:59
73.
Lange, M. ∙ Bergen, V. ∙ Klein, M. ...
CellRank for directed single-cell fate mapping
Nat. Methods. 2022; 19:159-170
74.
Van de Sande, B. ∙ Flerin, C. ∙ Davie, K. ...
A scalable SCENIC workflow for single-cell gene regulatory network analysis
Nat. Protoc. 2020; 15:2247-2276
75.
Waskom, M.
seaborn: statstical data visualization
J. Open Source Softw. 2021; 6:3021






Plaats een reactie ...

Reageer op "Diabetes: Harmine, een natuurlijke alkaloide, blijkt de insuline productie te herstellen bij diabetes patienten en lijkt uitstekende behandeling om diabetes 1 en 2 te genezen"


Gerelateerde artikelen
 

Gerelateerde artikelen

Diabetes medicijn Ozempic >> Diabetici hebben grotere kans >> Algemene informatie preventie >>